13F-HR filed by Velan Capital Investment Management LP
Velan Capital Investment Management LP filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-14, with 18 holding rows worth $106,938,590.
- Accession
- 0001848809-24-000011
- Filer
- CIK 1848809
- Filed
- 2024-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A holdings report, 20 entries on the cover page, a total value of $106,938,590 stated on the cover page (in dollars after the unit check, H1), rows summing to $106,938,590 with VALUE read as dollars as filed, 13F file number 028-21996. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 1,433,828 | $26,970,305 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 350,666 | $20,177,322 | dollars as filed | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 150,000 | $14,820,000 | dollars as filed | call |
| HERON THERAPEUTICS INC | 427746102 | COM | 6,986,744 | $13,903,621 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 331,190 | $8,514,895 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 800,000 | $3,880,000 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 300,000 | $3,000,000 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 1,290,323 | $2,529,033 | dollars as filed | |
| INSPIREMD INC | 45779A846 | COM | 904,029 | $2,422,798 | dollars as filed | |
| SCPHARMACEUTICALS INC | 810648105 | COM | 517,668 | $2,360,566 | dollars as filed | |
| TELA BIO INC | 872381108 | COM | 747,410 | $1,890,947 | dollars as filed | |
| OPTINOSE INC | 68404V100 | COM | 2,146,608 | $1,438,227 | dollars as filed | |
| ZEVRA THERAPEUTICS INC COM NEW | 488445206 | Stock | 200,000 | $1,388,000 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 574,000 | $1,050,420 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 50,000 | $1,031,500 | dollars as filed | |
| SKYE BIOSCIENCE INC | 83086J200 | COM NEW | 211,071 | $825,288 | dollars as filed | |
| KIORA PHARMACEUTICALS INC | 49721T507 | COM | 122,223 | $447,336 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 83,333 | $288,332 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001848809-24-000011 | this filing | 2024-11-14 | acceptance time not in the bulk data set |